£78.05

Springer Multiple System Atrophy

13 black & white illustrations, 20 colou

Price data last checked 14 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£78 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 77 days · 77 data points (no recent data)

Historical
Generating forecast…
£80.23 £77.83 £78.36 £78.88 £79.40 £79.92 £80.45 21 May 2026 09 June 2026 28 June 2026 17 July 2026 05 August 2026

Price Distribution

Price distribution over 77 days • 3 price levels

Days at Price
Current Price
1 day · current 3 days 73 days 0 18 37 55 73 £78 £79 £80 Days at Price

Price Analysis

Most common price: £80 (73 days, 94.8%)

Price range: £78 - £80

Price levels: 3 different prices over 77 days

Description

This textbook provides a comprehensive monography on multiple system atrophy (MSA), a rare and fatal neurodegenerative disorder that presents with autonomic failure and either parkinsonism (MSA-P) or cerebellar ataxia (MSA-C).The underlying neuropathology of MSA is characterized by striatonigral degeneration (SND), olivopontocerebellar atrophy (OPCA) and unique oligodendroglial cytoplasmic alpha-synuclein inclusions. MSA is therefore classified among the alpha-synucleinopathies such as Parkinson`s disease, pure autonomic failure and dementia with Lewy bodies. Over the last decade there have been important advances in early diagnosis, pathogenesis research and clinical trial activity. The monography will cover the entire spectrum ranging from molecular and genetic work to symptomatic and interventional therapies. The book is written for movement disorder clinicians and basic neuroscientists interested in degenerative movement disorders.

Key Features

Multiple System Atrophy

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers
82% match

Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers

Springer

£117.61 31 Jul 2026
Neurodegenerative Disorders: A Clinical Guide
81% match

Neurodegenerative Disorders: A Clinical Guide

Springer

£60.42 05 Aug 2026
Multiple Sclerosis: Practical Comprehensive Essentials
80% match

Multiple Sclerosis: Practical Comprehensive Essentials

£75.00 14 Aug 2026
Atlas of Neuromuscular Diseases: A Practical Guideline
80% match

Atlas of Neuromuscular Diseases: A Practical Guideline

Springer

£141.67 06 Aug 2026
Atypical Parkinsonian Disorders: Clinical and Research Aspects (Current Clinical Neurology)
80% match

Atypical Parkinsonian Disorders: Clinical and Research Aspects (Current Clinical Neurology)

Humana

£59.23 04 Aug 2026
Molecular Biology of Multiple Sclerosis
80% match

Molecular Biology of Multiple Sclerosis

Wiley-Blackwell

Price unavailable
Pathogenesis of Neurodegenerative Disorders (Contemporary Neuroscience)
80% match

Pathogenesis of Neurodegenerative Disorders (Contemporary Neuroscience)

Humana

£147.14 05 Aug 2026
Neuroacanthocytosis Syndromes
79% match

Neuroacanthocytosis Syndromes

Springer

£108.01 04 Aug 2026
Handbook of Non-Motor Symptoms in Parkinson's Disease
79% match

Handbook of Non-Motor Symptoms in Parkinson's Disease

Springer

£39.77 06 Aug 2026
Polyglutamine Disorders: 1049 (Advances in Experimental Medicine and Biology, 1049)
79% match

Polyglutamine Disorders: 1049 (Advances in Experimental Medicine and Biology, 1049)

Springer

£92.22 13 Aug 2026
Stem Cell-based Therapy for Neurodegenerative Diseases: 1266 (Advances in Experimental Medicine and Biology, 1266)
79% match

Stem Cell-based Therapy for Neurodegenerative Diseases: 1266 (Advances in Experimental Medicine and Biology, 1266)

Springer

£71.18 08 Aug 2026
Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)
79% match

Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)

Springer

£107.23 18 Aug 2026
Movement Disorders Rehabilitation
79% match

Movement Disorders Rehabilitation

Springer

£85.16 08 Aug 2026
Movement Disorders Rehabilitation
79% match

Movement Disorders Rehabilitation

Springer

£65.61 04 Aug 2026
Movement Disorders in Dementias
79% match

Movement Disorders in Dementias

Springer

£102.53 05 Aug 2026
Movement Disorders in Dementias
79% match

Movement Disorders in Dementias

Springer

£80.64 04 Aug 2026
Molecular Basis of Multiple Sclerosis: The Immune System: 51 (Results and Problems in Cell Differentiation, 51)
79% match

Molecular Basis of Multiple Sclerosis: The Immune System: 51 (Results and Problems in Cell Differentiation, 51)

Springer

£144.64 08 Aug 2026
Multiple Sclerosis: Bench to Bedside: Global Perspectives on a Silent Killer: 958 (Advances in Experimental Medicine and Biology, 958)
78% match

Multiple Sclerosis: Bench to Bedside: Global Perspectives on a Silent Killer: 958 (Advances in Experimental Medicine and Biology, 958)

Springer

£109.24 10 Aug 2026
Movement Disorders Curricula
78% match

Movement Disorders Curricula

Springer

£94.61 04 Aug 2026
Multiple Sclerosis: Diagnosis and Therapy
78% match

Multiple Sclerosis: Diagnosis and Therapy

Wiley-Blackwell

£71.99 01 Aug 2026
NEUROPATHOLOGY: New Research (Neuroscience Research Progress; Neurology - Laboratory and Clinical Research Developments)
78% match

NEUROPATHOLOGY: New Research (Neuroscience Research Progress; Neurology - Laboratory and Clinical Research Developments)

£105.68 08 Aug 2026
Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)
78% match

Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)

Springer

£114.71 05 Aug 2026
Early Indicators Early Treatments Neuroprotection in Multiple Sclerosis (Topics in Neuroscience)
78% match

Early Indicators Early Treatments Neuroprotection in Multiple Sclerosis (Topics in Neuroscience)

Springer

£76.42 05 Aug 2026
Neuropsychiatric Disorders
78% match

Neuropsychiatric Disorders

Springer

£108.01 06 Aug 2026